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Background: Lactation has beneficial short term effects on maternal metabolic health, but the long term effects
are less well known.
Methods: We studied the association between lifetime duration of lactation and cardiovascular risk factors in
mothers later in life among 21,368 parous women aged 20 to 85 years attending the second Nord-Trøndelag
Health Study (HUNT2) in 1995–1997, Norway, a cross-sectional population-based study. General linear modelling
was used to calculate mean values of known cardiovascular risk factor levels in five categories of lifetime duration
of lactation. Logistic regression was conducted to estimate odds ratios of hypertension, obesity and diabetes.
Results: Among women aged 50 years or younger, lifetime duration of lactation was significantly and inversely
associated with body mass index (P-trend, < 0.001), waist circumference (P-trend, < 0.001), systolic and diastolic
blood pressure (both P-trends, < 0.001), and serum levels of triglycerides, total cholesterol and low density
lipoprotein cholesterol (all P-trends, < 0.001) after adjustment for covariates. Parous women aged 50 years or
younger who had never lactated had higher prevalence of hypertension, obesity and diabetes. In this age group,
compared to women who had lactated for 24 months or more, parous women who had never lactated had an OR
for hypertension of 1.88 (95% CI 1.41, 2.51), an OR for obesity of 3.37 (95% CI 2.51, 4.51) and an OR for diabetes of
5.87 (95% CI 2.25, 15.3). Among women older than 50 years there were no clear associations.
Conclusion: Lifetime duration of lactation was associated with long term reduced cardiovascular risk levels in
mothers aged 50 years or younger.Background
Cardiovascular disease is the most common cause of
death in women in the western world, and among its
major modifiable risk factors are hypertension, dyslipi-
daemia, obesity and type 2-diabetes [1]. Lactation is a
factor unique to women that may be associated with all
these risk factors, and several studies have shown that it
may affect them favourably [2-4]. Moreover, such advan-
tages may persist several years post-weaning [5-13].
However, previous studies evaluating the association be-
tween lactation and maternal cardiovascular health have
suffered from being short-term, having small sample sizes,
or samples from selected populations or populations with* Correspondence: siv.t.natland@ntnu.no
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reproduction in any medium, provided the orlow breastfeeding rates. Norway has one of the highest
breastfeeding rates in Europe, with 80% of the infants still
being breastfed at six months [14]. We have therefore
studied the association between lifetime duration of lacta-
tion and maternal cardiovascular risk factors later in life
in a large unselected Norwegian population sample (about
35,000 women) in which breastfeeding was common and
breastfeeding duration was long.
Methods
Study population
The Nord-Trøndelag Health Study (HUNT) is a
population-based health survey aiming at the total adult
population >19 years of age in the county of Nord-
Trøndelag, Norway. Data collection and methods have
been described in detail elsewhere [15]. Briefly, the second
HUNT study (HUNT2) took place between 1995 andl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and a clinical examination including standardised mea-
surements of height, weight, waist circumference and
blood pressure, as well as non-fasting measurements of
blood glucose and serum lipids. The first questionnaire
was sent by mail along with an invitation for a clinical
examination. The questionnaire form included questions
about general health and lifestyle, and the participants
were requested to bring it to the physical examination. A
second, more detailed questionnaire containing queries on
number of live births and corresponding lactation history,
as well as illnesses, medical treatment, lifestyle and socio-
economic factors was distributed during the examination,
to be completed at home and returned by mail.
Among 47,312 women invited to HUNT2, a total of
35,280 (75.5%) women participated. For this study, rea-
sons for exclusions were non-response to the second
questionnaire (n = 5,061), current pregnancy (n = 605),
age > 85 years (n = 343), non-attendance at the clinical
examination (n = 355), self-report of infarction (n = 1),
stroke (n = 9), angina (n = 12), diabetes prior to the first
live birth (n = 43), less than one year since last child
birth (n = 257) or unknown lactation history (n = 2 206),
leaving 26,388 women as eligible for the analyses, of
whom 21,368 women had given birth to at least one
child. For the analyses of blood pressure data we further
excluded those who reported current or previous antihy-
pertensive medication (n = 3 061 among parous women,
n = 682 among nulliparous women). For the analyses of
low density lipoprotein cholesterol we excluded those
with triglyceride concentrations of 4.5 mmol/L or more
(n = 321 among parous women, n = 78 among nullipar-
ous women).
Lactation history
Lactation history was self-reported by the women in the
second questionnaire. For each live birth, the women
reported the year of birth and corresponding lactation
duration in whole months (“How many months did you
breastfeed?”). Lifetime duration of lactation was calcu-
lated as the sum of lactation duration for all live births
and categorised into five levels (none, 1–6, 7–12, 13–23,
and ≥24 months).
Clinical measurements
Height was measured without shoes to the nearest
1.0 cm and weight wearing light clothing to the nearest
0.5 kg. Body mass index was calculated as weight (kg)
divided by the squared value of height (m2). Waist cir-
cumferences were measured with a flexible steel band
with the participants standing upright, and the numbers
were rounded to the nearest 1.0 cm. Waist circumfer-
ence was measured horizontally at the height of the um-
bilicus [15].Blood pressure was measured by specially trained
nurses or technicians with oscillometric Dinamap 845 XT
(W Critikon, Tampa, FL) after adjustment of the cuff size
according to the arm circumference. After an initial two
minutes’ rest, the blood pressure was automatically mea-
sured three times at intervals of one minute. In this study,
we used the mean value of the second and third measure-
ment of systolic and diastolic blood pressure.
The blood sample (non-fasting) drawn from all partici-
pants was centrifuged at the screening station and, on
the same day, transported in a cooler to the laboratory.
Serum lipids were analysed at the Central Laboratory,
Levanger Hospital, Nord-Trøndelag Hospital Trust, using
a Hitachi 911 Autoanalyser (Hitachi, Mito, Japan), apply-
ing reagents from Boehringer Mannheim (Mannheim,
Germany). Total serum cholesterol, high density lipopro-
tein (HDL) cholesterol and triglycerides were measured by
an enzymatic colorimetric method, and HDL cholesterol
was measured after precipitation with phosphotungstate
and magnesium ions. Glucose was measured using an en-
zymatic hexokinase method. The day-to-day coefficients
of variation were 1.3-1.9% for total cholesterol, 2.4% for
HDL-cholesterol, 0.7-1.3% for triglycerides and 1.3-2.0%
for glucose.
Low density lipoprotein (LDL) cholesterol was calculated
using the Friedewald formula: LDL cholesterol = total
serum cholesterol – HDL cholesterol – one-fifth of the tri-
glyceride concentration [16]. LDL was only calculated
in participants with triglyceride concentrations lower
than 4.5 mmol/L.
Analyses
In order to examine whether the effects of lactation dur-
ation were modified by age, we conducted analysis strati-
fied by age (≤ 50 years and > 50 years) and also tested for
statistical interaction by including a product term of
lactation duration and age ±50 years in the regression
model. We used a general linear model to calculate
mean values of body mass index, waist circumference,
systolic and diastolic blood pressure, serum lipid levels
and blood glucose levels in five categories of lactation,
and to estimate adjusted mean difference with 95% con-
fidence intervals (CI) between the categories. Previous
studies have shown beneficial maternal metabolic effects
with increasing duration of lactation [6,11,17]. Hence,
lifetime duration of lactation for ≥24 months, the cat-
egory with the longest lactation duration, was used as a
reference category, as this was assumed to be the most
beneficial lactation duration. Lipid and glucose concen-
trations were log-transformed due to non-normal distri-
bution, and hence we calculated geometric means and
crude and adjusted differences in percent between the
categories for each lipid and for glucose. P-values for lin-
ear trend were calculated first across the five categories
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tation duration, excluding the ‘never lactated’ group, by
treating the categories as an ordinal variable in the regres-
sion model. All associations were adjusted for potential
confounding, with maternal age, education (primary school,
secondary school, college/university and unknown), smok-
ing status (current, former or never smoked), hours of
physical activity per week (no activity, <3 hours light or <1
hour hard activity, >3 hours light or 1 hour hard ac-
tivity, >1 hour hard activity, and unknown), marital status
(unmarried, divorced, widowed and married/cohabiting)
and parity (1, 2, 3 or≥ 4 children). In analyses of serum
lipids and blood glucose we also adjusted for time since
last meal. In supplementary analyses, we adjusted first for
time since last birth, and then for body mass index. We
also did the analyses described above comparing nullipar-
ous and parous women.
In additional analyses, we used logistic regression to esti-
mate crude and adjusted odds ratios (ORs) with 95% CIs of
hypertension (≥ 140/90 mmHg or current antihypertensive
treatment), obesity (body mass index≥30 kg/m2), and dia-
betes (‘yes’ versus ‘no’ to the question ‘Do you have or have
you had diabetes?’ or blood glucose≥ 11.1 mmol/L) asso-
ciated with five categories of lactation duration. We also
did corresponding analyses comparing nulliparous and par-
ous women.
All statistical tests were two-sided, and all analyses
were performed using SPSS for Windows (version 16,
SPSS Inc., Chicago; IL, USA).Ethical approval
The study was approved by the Norwegian Regional
Committees for Medical and Health Research Ethics and
by the Norwegian Data Inspectorate. Informed consent
was given by all participants in the HUNT-study.Results
The parous women had a mean age of 50.4 years when
attending HUNT2, they reported a median parity of two
live births, a median lifetime duration of lactation of
13 months and time since the last delivery was on average
21.1 years (data not shown). The majority (96.7%) of the
21,368 parous women had breastfed one or more children,
and approximately one in five women (21.4%) reported a
lifetime duration of lactation longer than 24 months.
Across the lactation categories, there were significant dif-
ferences in maternal age, educational level, smoking sta-
tus, the level of physical activity, marital status and parity
in our study (Table 1). Furthermore, the variables that we
a priori considered as confounders, namely: educational
level, smoking status, level of physical activity, marital sta-
tus and parity, were all associated with the outcome vari-
ables in our study (data not shown).There was evidence of statistical interaction between
age at participation (± 50 years) and lactation duration for
several of the outcome variables under study (P-values
from interaction tests; < 0.001 for BMI; < 0.001 for waist
circumference; 0.043 for systolic blood pressure; < 0.001
for triglycerides; < 0.001 for total cholesterol, and 0.011
for HDL-cholesterol). Thus, the remainder of the analyses
were stratified by age. Overall, there was an inverse associ-
ation between lifetime duration of lactation and both body
mass index (P-trend, < 0.001) and waist circumference
(P-trend= 0.01) among women 50 years of age or younger
(Table 2). After adjusting for potential confounders,
women 50 years of age or younger who reported no lacta-
tion had a body mass index that was 2.5 kg/m2 (95% CI
2.0, 3.0) higher and a waist circumference that was 5.3 cm
(95% CI 4.2, 6.5) wider than the reference group of women
who had lactated≥ 24 months (Table 2). Adjusting for
time since last birth did not change these estimates.
Among women older than 50 years, there were no signifi-
cant relations between duration of lactation and body
mass index. However, women older than 50 years who
reported no lactation had a waist circumference that
was 1.5 cm wider than the reference group who had
lactated ≥ 24 months.
A similar pattern was observed in age-stratified ana-
lysis of systolic and diastolic blood pressure, shown in
Figure 1. In multi-adjusted analysis, women 50 years of
age or younger who had never lactated had 4.9 mmHg
(95% CI 3.2, 6.6) higher systolic blood pressure and
2.9 mmHg (95% CI 1.8, 4.1) higher diastolic blood pres-
sure than women who had lactated ≥ 24 months (both
P-trends, < 0.001). Among women older than 50 years,
there were no significant relationships between duration
of lactation and systolic or diastolic blood pressure. Add-
itional adjustment for body mass index and time since last
birth attenuated the estimates of both systolic and dia-
stolic blood pressure among women 50 years or younger,
whereas the estimates among women older than 50 years
remained largely similar (data not shown).
The analysis of lifetime duration of lactation and levels
of triglycerides, total cholesterol and LDL-cholesterol also
showed an inverse pattern and an apparent dose–response
relationship (all P-trends, < 0.001) among women 50 years
or younger, whereas among women older than 50 years
no significant associations were found. In analyses of log-
transformed lipid values, women 50 years or younger who
had never lactated had 17% (95% CI 11, 24) higher trigly-
ceride levels, 5% (95% CI 3, 7) higher total cholesterol levels
and 8% (95% CI 4, 11) higher LDL-cholesterol levels than
women who had lactated≥24 months (Table 3). Additional
adjustments for time since last birth did not change these
estimates, whereas additional adjustments for body mass
index attenuated the estimates (data not shown). The
results for HDL cholesterol showed a somewhat different
Table 1 Characteristics of women in the HUNT2-study, Norway, 1995–97 (N=26,388)
Nulliparous women Parous women
Lifetime duration of lactation (months)










Age, yrs, mean (SD) 44.7 (21.6) 50.7 (13.7) 48.4 (14.5) 49.3 (14.9) 50.1 (14.8) 53.8 (15.7)
Age at delivery of first child, yrs, mean (SD) - 24.2 (5.1) 23.3 (4.4) 23.3 (4.2) 23.4 (3.9) 23.2 (3.7)
Parity,
Para 1 (%) - 29.9 30.8 17.2 2.5 0.4
Para 2 (%) - 38.3 45.1 44.0 45.1 12.9
Para 3 (%) - 21.7 17.4 26.7 35.0 41.2
Para 4 or greater (%) - 10.1 6.8 12.0 17.5 45.5
University/college education (%)b 26.4 13.2 13.4 18.0 21.7 22.4
Never smoked (%) 62.2 37.3 36.7 45.7 50.9 60.5
High physical activityc,d (%) 28.7 14.6 17.6 18.2 20.9 18.2
Unmarried/divorced (%) 61.6 24.4 28.7 23.2 16.5 11.1
Hypertensione (%) 37.5 47.2 36.3 37.5 37.5 44.9
Obesityf (%) 17.0 27.9 18.7 18.0 16.3 21.2
Diabetes (%)g 3.0 4.4 1.9 2.0 2.4 3.7
Abbreviation: SD, standard deviation.
aContinuous variables presented as mean (SD), categorical variables presented as % in each category of lactation.
b Number of women in the category unknown: n = 823.
c High physical activity defined as≥ 1 hour hard physical activity per week.
d Number of women in the category unknown: n = 2,059.
eHypertension defined as≥ 140/90 mmHg or current antihypertensive medication.
f Obesity defined as body mass index≥ 30 kg/m2.
gDiabetes defined as blood glucose ≥ 11.1 mmol/L or self reported diabetes in the questionnaire.
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tated had 4% (95% CI 1, 6) lower HDL cholesterol levels
than women who had lactated ≥ 24 months (P-trend,
0.008). Additional adjustments for time since last birth did
not change these estimates, whereas no associations
remained after adjustments for body mass index. As in the
analyses of the other serum lipids, there were no signifi-
cant associations among women older than 50 years.
Contrary to blood pressure and serum lipids, there was
no statistically significant linear trend across the lactation
categories in blood glucose levels (Table 3) in either of the
two age groups. However, in women 50 years or younger
there was weak evidence of a dose-dependent association
(P-trend, = 0.06), but no associations remained after add-
itional adjustments for body mass index (data not shown).
Of the total study sample of parous women (n= 21,368),
39.0% of the women had hypertension, 18.7% were obese
and 2.5% had known diabetes (Table 4). The correspond-
ing prevalences among nulliparous women (n= 5,020),
were 37.5%, 17.0% and 3.0%, respectively. Among women
50 years or younger, lifetime duration of lactation was
inversely associated with the prevalence of hypertension
(P-trend, < 0.001), obesity (P-trend, < 0.001) and diabetes
(P-trend, = 0.004). Parous women 50 years or younger
who had never lactated had an almost doubled risk for
hypertension, more than three times the risk of obesityand more than five times the risk of diabetes compared to
women in the reference group who had lactated
for≥ 24 months (Table 4). Among women older than
50 years no associations were found. Adjusting for
time since last birth did not change these estimates,
whereas adjusting for body mass index attenuated the
estimates of both risk for hypertension and for dia-
betes (data not shown).
Discussion
In this large population-based study, we found that pro-
longed lifetime lactation was associated with a more
favourable cardiovascular risk profile among women
50 years or younger. Parous women≤ 50 years who had
never lactated were more likely to have developed hyper-
tension, obesity and diabetes than women who had the
longest lactation duration. Furthermore, there were strong
indications of a dose–response association between the
total duration of lactation and a favourable cardiovascular
risk profile. Although the largest difference was found for
women who had never lactated compared to those who
had ever lactated, our analyses showed that the associa-
tions remained significant also within the lactation cat-
egories. Among women older than 50 years, only waist
circumference and possibly diabetes were associated with
lactation duration.
Table 2 Body mass index and waist circumference in nulliparous and parous women (n= 26,388)
Women≤ 50 years of age (n = 14,677) Women> 50 years of age (n = 11,711)
No. Crude mean Adjusted meana 95 % CI No. Crude mean Adjusted meana 95 % CI
BMI (kg/m2)
Nulliparous women 3,011 24.8 25.8 25.5, 26.1 2,009 27.3 26.9 26.6, 27.1
Parous women 11,666 25.4 25.6 25.3, 25.9 9,702 27.5 27.3 27.1, 27.5
P-valueb 0.026 <0.001
Months of lifetime lactation
Never 360 27.5 27.6 27.1, 28.1 345 27.7 27.7 27.2, 28.3
1–6 2,587 25.7 26.1 25.8, 26.5 1,834 27.1 27.2 26.9, 27.6
7–12 3,038 25.4 25.7 25.4, 26.0 2,363 27.2 27.2 26.9, 27.5
13–23 3,513 25.1 25.3 25.0, 25.6 2,753 27.4 27.3 27.0, 27.6
≥ 24 2,168 25.1 25.1 24.8, 25.5 2,407 28.2 27.6 27.2, 27.9
P- trendc <0.001 0.542
P- trendd <0.001 0.675
Waist cirmcumference (cm)
Nulliparous women 3,012 76.1 79.2 78.5, 80.0 2,009 85.3 84.2 83.6, 84.7
Parous women 11,919 78.8 79.3 78.6, 80.0 9,702 85.0 85.0 84.5, 85.5
P-valueb 0.723 0.004
Months of lifetime lactation
Never 360 83.4 83.9 82.6, 85.2 345 86.3 86.9 85.7, 88.2
1–6 2,587 79.5 80.5 79.7, 81.4 1,834 84.3 85.1 84.3, 85.9
7–12 3,038 78.8 79.7 78.9, 80.5 2,363 84.3 84.7 83.9, 85.5
13–23 3,513 78.1 78.9 78.1, 79.8 2,753 84.4 84.6 83.8, 85.4
≥ 23 2,168 78.4 78.6 77.7, 79.4 2,407 86.8 85.4 84.5, 86.2
P- trendc <0.001 0.03
P- trendd <0.001 0.085
Abbreviations: No, number; CI, confidence interval; BMI, body mass index.
a For nulliparous women: Adjusted for maternal age, smoking status, physical activity, education and marital status. For parous women: Adjusted for maternal age,
smoking status, physical activity, education, marital status and parity.
b P-value between nulliparous vs parous women. Adjusted for maternal age, smoking status, physical activity, education and marital status.
cP-trend across all five categories of lifetime lactation duration, including the category “never”.
d P-trend across four categories of lifetime lactation duration, excluding the category “never”.
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ing that the favourable effects of lactation on maternal
metabolic health persist post weaning [7,8,11,17-20] and
thereby further supporting the notion that lactation may
induce long-term beneficial effects on maternal blood
pressure, weight [21], diabetes [6,18], components of the
metabolic syndrome [5,19] and cardiovascular health
[7,11,17]. Previous studies have shown that the beneficial
effect of lactation on cardiovascular risk factors seems to
wane with time since last birth [6,11,18]. Adjusting for
this period did not change the estimate in our study. On
the other hand, the stronger associations observed among
women aged≤ 50 years compared to those aged >50 years
could possibly be due to the shorter period since last birth.
The present study was conducted in a large and unse-
lected population with a wide age range and a high par-
ticipation rate. Breastfeeding was common, and thisobservation is consistent with other studies showing that
breastfeeding rates in Norway are among the highest in
industrialised countries [22]. We therefore have a large
sample size of women who have lactated. Combined with
the standardised measurements of lipids, anthropometric
measures and blood pressure, it provides a unique
opportunity to study the association of lactation and
cardiovascular risk factors and whether differences
exist by duration of lactation.
However, the cross sectional study design calls for a
cautious interpretation of the findings, as in all observa-
tional studies. It is possible that women who breastfeed
their children have a better health status, healthier life-
styles and higher socioeconomic status than women who
do not breastfeed [23]. Given the high rates of breast-
feeding among Norwegian women, the group of women
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Figure 1 Adjusted mean systolic and diastolic blood pressure (with 95%CI) in nulliparous and parous women. For nulliparous women
(n = 4,338): Adjusted for age, smoking, physical activity, education and marital status. For parous women (n =18,307): Adjusted for age, smoking,
physical activity, education, marital status and parity. (Number of women in each category of lifetime duration of breastfeeding among
women≤ 50 years of age n= 11,150): 0 months: n = 335, 1–6 months: n = 2,455, 7–12 months: n = 2,893, 13–23 months: n = 3,380, 24+ months:
n = 2,087. Number of women in each category of lifetime duration of breastfeeding among women> 50 years of age (n = 7,157): 0 months:
n = 251, 1–6 months: n = 1,429, 7–12 months: n = 1,770, 13–23 months: n = 2,057, 24+ months: n = 1,650).
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women who had never lactated in our study differed in
major confounders than might be expected in popula-
tions where breastfeeding rates are lower.
A previous study among Norwegian women found that
maternal age, education and smoking were among the
most important factors associated with lactation duration
[22]. In addition to these factors, we found significant dif-
ferences across the lactation categories in the level of
physical activity, marital status, and parity in our study.
Although all of these factors are known to be associated
with risk of cardiovascular disease, adjusting for them did
not materially change the estimated associations. How-
ever, residual confounding due to unmeasured and
unknown factors cannot be ruled out, such as pre-
pregnancy and early postpartum health status. Women
with gestational diabetes mellitus are at an increased risk
of developing type 2 diabetes [24]. Furthermore, gesta-
tional diabetes mellitus may have a role in impacting
breastfeeding initiation and success, and could thus act as
a major confounder. In a recent study, longer duration oflactation was associated with lower incidence of the meta-
bolic syndrome both among women with and without a
history of gestational diabetes mellitus, and the findings
were particularly striking for women who developed ges-
tational diabetes mellitus during their pregnancy [10].
In our study, women reporting a diagnosis of diabetes
prior to first pregnancy were excluded from our ana-
lyses. Nevertheless, the lack of data on the history of
gestational diabetes mellitus during pregnancy is a
limitation of our study.
Moreover, the potential for reverse causation must be
considered when interpreting the results from the present
study. Obesity [25,26] and type 1 diabetes [27] have been
linked to difficulties with lactation, and hence shorter lacta-
tion duration could be a marker for an already existing ab-
normal metabolic profile influencing whether the women
lactate and for how long. Unfortunately, we did not have
pre-pregnancy measurements of weight and height and
could therefore not adjust for pre-pregnant body mass
index. However, when we adjusted for body mass index
measured at study participation in supplementary analyses,
Table 3 Triglycerides, total-, HDL- and LDL-cholesterol and blood glucose (log-transformed) in nulliparous and parous
women (n =26,388)











Nulliparous women 3,011 1.09 1.21 1.17, 1.26 2,009 1.66 1.58 1.54, 1.62
Parous women 11,666 1.14 1.16 1.12, 1.20 9,702 1.63 1.63 1.59, 1.66
P-valueb <0.001 0.02
Months of lifetime lactation
Never 360 1.34 1.30 1.22, 1.38 345 1.64 1.70 1.61, 1.80
1–6 2,587 1.22 1.22 1.17, 1.27 1,834 1.55 1.61 1.55, 1.67
7–12 3,038 1.15 1.17 1.13, 1.22 2,363 1.59 1.63 1.57, 1.68
13–23 3,513 1.11 1.14 1.10, 1.19 2,753 1.64 1.65 1.59, 1.70
≥ 24 2,168 1.08 1.11 1.07, 1.16 2,407 1.70 1.63 1.57, 1.69
P- trendc <0.001 0.890
P- trendd <0.001 0.462
Cholesterol (mmol/L)
Nulliparous women 3,011 4.95 5.35 5.27, 5.42 2 009 6.73 6.56 6.50, 6.63
Parous women 11,666 5.27 5.19 5.13, 5.25 9 702 6.58 6.50 6.45, 6.55
P-valueb <0.001 0.06
Months of lifetime lactation
Never 360 5.56 5.47 5.35, 5.59 345 6.48 6.47 6.33, 6.61
1–6 2,587 5.38 5.37 5.29, 5.45 1,834 6.52 6.51 6.42, 6.59
7–12 3,038 5.28 5.31 5.23, 5.39 2,363 6.54 6.52 6.43, 6.60
13–23 3,513 5.20 5.23 5.16, 5.31 2,753 6.61 6.58 6.49, 6.66
≥ 24 2,168 5.17 5.20 5.12, 5.28 2,407 6.62 6.51 6.42, 6.60
P- trendc <0.001 0.362
P- trendd <0.001 0.552
HDL-cholesterol (mmol/L)
Nulliparous women 3,011 1.47 1.48 1.46, 1.51 2 009 1.47 1.50 1.48, 1.52
Parous women 11,666 1.44 1.42 1.39, 1.44 9 702 1.46 1.45 1.43, 1.46
P-valueb <0.001 <0.001
Months of lifetime lactation
Never 360 1.39 1.38 1.34. 1.43 345 1.46 1.44 1.39. 1.48
1–6 2,587 1.41 1.41 1.39. 1.44 1,834 1.48 1.45 1.42. 1.48
7–12 3,038 1.44 1.43 1.40. 1.46 2,363 1.47 1.45 1.42. 1.48
13–23 3,513 1.45 1.44 1.41. 1.47 2,753 1.46 1.45 1.42. 1.48
≥ 24 2,168 1.45 1.43 1.40. 1.47 2,407 1.41 1.43 1.40. 1.46
P- trendc 0.008 0.362
P- trendd 0.06 0.265
LDL-cholesterole (mmol/L)
Nulliparous women 2,999 3.15 3.49 3.42, 3.56 1 943 4.76 4.58 4.52, 4.65
Parous women 11,576 3.48 3.43 3.37, 3.49 9 471 4.64 4.57 4.52, 4.62
P-valueb 0.006 0.661
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Table 3 Triglycerides, total-, HDL- and LDL-cholesterol and blood glucose (log-transformed) in nulliparous and parous
women (n =26,388) (Continued)
Months of lifetime lactation
Never 353 3.77 3.70 3.58, 3.83 337 4.55 4.55 4.42, 4.69
1–6 2,564 3.60 3.60 3.52, 3.68 1,798 4.57 4.57 4.49, 4.66
7–12 3,021 3.49 3.53 3.46, 3.61 2,316 4.58 4.58 4.50, 4.67
13–23 3,482 3.41 3.45 3.38, 3.53 2,677 4.64 4.64 4.55, 4.72
≥ 24 2,156 3.40 3.44 3.36, 3.52 2,343 4.58 4.58 4.49, 4.67
P- trendc <0.001 0.396
P- trendd <0.001 0.509
Glucose (mmol/L)
Nulliparous women 3,011 4.93 5.10 5.04, 5.16 2,009 5.61 5.52 5.46, 5.59
Parous women 11,666 5.02 4.99 4.94, 5.04 9,702 5.53 5.57 5.52, 5.62
P-valueb <0.001 0.183
Months of lifetime lactation
Never 360 5.15 5.10 5.00, 5.20 345 5.51 5.62 5.48, 5.76
1–6 2,587 5.04 5.02 4.96, 5.09 1,834 5.43 5.53 5.44, 5.62
7–12 3,038 5.01 5.00 4.94,5.06 2,363 5.51 5.58 5.49, 5.66
13–23 3,513 5.02 5.00 4.94, 5.07 2,753 5.54 5.59 5.50, 5.67
≥ 24 2,168 5.01 4.99 4.92, 5.06 2,407 5.60 5.57 5.48, 5.66
P- trendc 0.06 0.587
P- trendd 0.232 0.268
Abbreviations: No. number; CI, confidence interval; HDL, high density lipoprotein; LDL, low density lipoprotein.
a For nulliparous women: Adjusted for maternal age, smoking status, physical activity, education, marital status and time since last meal. For parous women:
Adjusted for maternal age, smoking status, physical activity, education, marital status, time since last meal and parity.
b P-value between nulliparous vs parous. Adjusted for maternal age, smoking status, physical activity, education, marital status and time since last meal.
cP-trend across all five categories of lifetime lactation duration, including the category “never”.
d P-trend across four categories of lifetime lactation duration, excluding the category “never”.
eLDL was calculated only if serum triglycerides were lower than 4.5 mmol/L.
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substantially, with the exception of HDL-cholesterol. Obes-
ity may either precede [26] or follow lactation practices.
Thus, one may argue that body mass index measured at
study participation rather acts as an intermediate factor,
and hence should not be adjusted for as a confounder in
the analyses.
Diet accounts for much of the variation in coronary
heart disease risk [28]. The HUNT2 study was not
designed to measure dietary intake, and we had insuffi-
cient dietary data to adjust for dietary factors in our
analyses. However, previous studies have found that the as-
sociation between lactation and cardiovascular health per-
sists even after adjustment for dietary intake [5,7,11,17].
Another limitation of the study is the lack of data on lac-
tation intensity. Higher intensity of lactation has been asso-
ciated with improved fasting glucose and lower insulin
levels at 6–9 weeks postpartum in a previous study [29].
Data on lactation intensity could therefore possibly have
strengthened our estimates of associations among women
with higher, and attenuated the associations among womenwith lower, lactation intensity. Moreover, lactation was
assessed retrospectively. Nevertheless, studies have shown
that maternal recall of lactation is fairly valid and reliable
[30], even after 20 years [31]. However, even if misclassifica-
tion should exist, it is not likely to be differential according
to cardiovascular risk factors. Our observed estimates are
therefore likely to be conservative.
Furthermore, selection bias could have influenced our
results. However, a non-responder study showed that the
most important reason for non-attending the HUNT2-
study in the age group 20–69 was lack of time/moved
away, while in those aged 70 years or more, immobilising
and frequent follow-up by medical doctor were important
reasons [32]. We do not believe that reasons for non-
attending were unevenly distributed across the lactation
categories, and we find it unlikely that selection bias
would have altered the results in our study.
During pregnancy the maternal metabolism is pro-
foundly changed, and the changes that occur could the-
oretically increase women’s risk of metabolic disease.
These changes include accumulation of adipose tissue
Table 4 Odds ratio for hypertension, obesity and diabetes in nulliparous and parous women (n= 26,388)
Women≤ 50 years of age (n = 14,677) Women>50 years of age (n = 11,711)





Nulliparous women 3,011 367 1.0 (Ref.) 1.0 (Ref.) 2,009 1,514 1.0 (Ref.) 1.0 (Ref.)
Parous women 11,666 2,006 1.49 0.75 0.65, 0.89 9,702 6,331 0.61 0.88 0.77, 1.00
P-value <0.001 0.05
Months of lifetime lactation
Never 360 98 2.08 1.88 1.41, 2.51 345 110 0.85 1.26 0.96, 1.65
1–6 2,587 489 1.29 1.24 1.03, 1.49 1,834 719 0.61 0.88 0.75, 1.02
7–12 3,038 528 1.17 1.16 0.98, 1.37 2,363 864 0.69 0.93 0.80, 1.07
13–23 3,513 560 1.05 1.03 0.88, 1.21 2,753 996 0.70 0.89 0.78, 1.01
≥ 24 2,168 331 1.0 (Ref.) 1.0 (Ref.) 2,407 682 1.0 (Ref.) 1.0 (Ref.)
P- trendc <0.001 0.944
P- trendd 0.009 0.218
Obesitye No. No. obesity No. No. obesity
Nulliparous women 3,011 357 1.0 (Ref.) 1.0 (Ref.) 2,009 497 1.0 (Ref.) 1.0 (Ref.)
Parous women 11,666 1,501 1.10 0.82 0.70, 0.96 9,702 2 490 1.05 1.26 1.11, 1.43
P-value 0.013 <0.001
Months of lifetime lactation
Never 360 100 3.29 3.37 2.51, 4.51 345 97 0.87 1.17 0.89, 1.53
1–6 2,587 398 1.56 1.68 1.36, 2.06 1,834 429 0.68 0.92 0.79, 1.09
7–12 3,038 420 1.37 1.46 1.21, 1.77 2,363 552 0.68 0.88 0.76, 1.01
13–23 3,513 356 0.96 1.02 0.85, 1.23 2,753 668 0.72 0.89 0.78, 1.01
≥ 24 2,168 227 1.0 (Ref.) 1.0 (Ref.) 2,407 744 1.0 (Ref.) 1.0 (Ref.)
P- trendc <0.001 0.861
P- trendd <0.001 0.457
Diabetesf No. No. diabetes No. No. diabetes
Nulliparous women 3 011 20 1.0 (Ref.) 1.0 (Ref.) 2 009 129 1.0 (Ref.) 1.0 (Ref.)
Parous women 11 666 77 0.99 0.59 0.32, 1.11 9 702 466 0.74 1.01 0.80, 1.26
P-value 0.102 0.957
Months of lifetime lactation
Never 360 10 5.60 5.87 2.25, 15.3 345 21 0.71 1.29 0.78, 2.14
1–6 2 587 18 1.37 1.49 0.63, 3.53 1 834 64 0.57 0.71 0.50, 1.01
7–12 3 038 19 1.23 1.29 0.57, 2.89 2 363 91 0.51 0.74 0.55, 1.00
13–23 3 513 19 1.07 1.06 0.48, 2.33 2 753 131 0.92 0.89 0.69, 1.16
≥ 24 2 168 11 1.0 (Ref.) 1.0 (Ref.) 2 407 159 1.0 (Ref.) 1.0 (Ref.)
P- trendc 0.004 0.202
P- trendd 0.292 0.014
Abbreviations: No, number; OR, odds ratio; CI, confidence interval, Ref., reference category.
a Adjusted for maternal age, smoking status, physical activity, education and marital status. For parous women: maternal age, smoking status, physical activity,
education, marital status and parity.
bHypertension defined as≥ 140/90 mmHg or current antihypertensive treatment.
cP-trend across all five categories of lifetime lactation duration, including the category “never”.
d P-trend across four categories of lifetime lactation duration, excluding the category “never”.
eObesity defined as BMI≥ 30 kg/m.
fDiabetes defined as blood glucose ≥ 11.1 mmol/L or self reported diabetes in the questionnaire.
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pressure, [35] as well as a change of the quantity and
quality of circulating lipoproteins [36,37]. By the end of
the pregnancy, LDL cholesterol and triglyceride levels
are two to three times higher compared with pre-
pregnancy levels. In fact, some studies have shown that
increasing parity may increase risk of cardiovascular dis-
ease [38,39]. These studies do not, however, include data
on lactation. Our findings of a more favourable cardio-
vascular risk profile associated with lactation seem to
confirm the recent suggestion that lactation could affect
risk of metabolic disease by facilitating a faster resetting
of the maternal metabolism after pregnancy [40].
Lactation increases a mother’s metabolic expenditure by
an estimated 480 kcal/d [41], and although the association
between lactation and postpartum weight loss so far
remains inconclusive [21,42-45], lactation could reduce
cardiovascular risk by mobilising accumulated fat stores.
Furthermore, lactation provides a route for physiologic
excretion of large amounts of cholesterol, which could
explain the more speedy return of blood lipids to pre-
pregnancy levels observed in lactating mothers [3]. Add-
itionally, hormonal effects, such as those of prolactin and
oxytocin, may affect maternal blood pressure [46]. Our
data among women with an average time since last preg-
nancy of about 21 years suggest that these favourable
changes are persisting on a long term scale and are not
limited to the period of lactation. Among women older
than 50 years, however, we found no similar linear trend
in the association between lifetime duration of lactation
and cardiovascular risk factors as in younger women. Still,
women> 50 years who had never lactated had a signifi-
cantly higher body mass index, wider waist circumference,
higher lipid and glucose levels and higher prevalence of
hypertension, obesity and diabetes compared to women
who had lactated. Menopause appears to be a time of
transition to increased cardiovascular risk, including ad-
verse changes in serum lipid profile [47]. Hence, the car-
diovascular risk alterations occurring during the
menopausal transition may dilute the possible beneficial
effects of lactation on maternal metabolic health as shown
in previous studies [6,11,18].
Lactation may also improve insulin sensitivity and glu-
cose tolerance. Insulin levels and insulin/glucose ratios
are lower, and carbohydrate use and total energy ex-
penditure are higher, in the lactating women compared
to women who do not lactate [41]. Our data suggest a
relation between lactation and glucose levels later in life.
However, no statistically significant association with life-
time duration of lactation could be found in either age
group, although the association among women 50 years
or younger were close to significant. In contrast, the as-
sociation between lifetime duration of lactation and the
prevalence of diabetes was strong and significant in theyounger age group, although not among the older women,
further supporting the notion that the possible effect
wanes with time since last delivery. These mechanisms,
together with our results, indicate that lactation helps
women return to pre-pregnant metabolism more quickly
post partum, which could in turn affect metabolic disease
risk profile later in life.
Our results indicate that lactation may have a consider-
able impact on cardiovascular risk factors. The difference in
systolic/diastolic blood pressure between women 50 years
or younger who had never lactated and women who had
lactated for 24 months or more is similar to the blood
pressure-lowering effect of salt reduction (4/2 mm Hg)
among normotensive individuals [48]. Furthermore, it has
been estimated that a 10% reduction in serum cholesterol
could halve the risk of ischaemic heart disease at age 40
[49], and hence the 5% difference in total cholesterol levels
observed between women 50 years or younger who had
never lactated, and women who had lactated more than
24 months, could represent a substantial risk reduction.
Also, the 17% difference in triglycerides between women
50 years or younger who had never lactated and women
who had lactated 24 months or more must be added to this
altered cardiovascular disease risk pattern.Conclusions
In conclusion, this large population-based study showed
that lactation is associated with a more favourable cardio-
vascular risk profile in mothers later in life, and that the
beneficial effects are most prominent among women
50 years or younger. Lactation may hence reduce the ad-
verse pregnancy-related changes in cardiovascular risk fac-
tors, with effects lasting even beyond the childbearing
years. If the observed associations are causal, lactation
could have substantial potential for reducing women’s risk
of cardiovascular disease. Additional studies are needed to
confirm the observed protective associations and their
underlying mechanisms.
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